is an oral drug manufactured by Novartis for treatment of Irritable Bowel Syndrome (IBS) with constipation in women. Zelnorm was approved by U.S. Food and Drug Administration in 2002 for treatment of Irritable Bowel Syndrome. Later in 2004 it was also approved for the treatment of Chronic Idiopathic Constipation (CIC) in all the patients below 65 years of age. On 30th March 2007, FDA asked Novartis to recall Zelnorm from the market.

Previous ArticleIowa Woman Sues Makers of Zelnorm Next ArticleZelnorm: Uses and Medifacts
Verdicts and Settlements
Contact Us

Subscribe Now!

[contact-form-7 404 "Not Found"]

Follow Us!

Unsafe Drugs has numerous resources on drug side effects,nutritional supplements, vitamins, and health products.

Site best viewed in Google Chrome, Firefox, Opera, Safari, IE browsers